img

Global and United States Generic Drug Intermediates CDMO Services Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global and United States Generic Drug Intermediates CDMO Services Market Report & Forecast 2024-2034

Generic Drug Intermediates CDMO (Contract Development and Manufacturing Organization) Services refer to the outsourcing of research, development, and manufacturing processes related to the production of generic drug intermediates. CDMOs specialize in providing comprehensive services such as process development, optimization, scale-up, and commercial manufacturing of intermediates for generic drugs. These services include synthesis of key chemical compounds and intermediates that are essential in the production of generic pharmaceutical products. Generic Drug Intermediates CDMO Services offer pharmaceutical companies a cost-effective and efficient solution for the development and manufacturing of generic drugs, helping them meet regulatory requirements and bring quality, affordable medications to the market.
Market Analysis and InsightsGlobal and United States Generic Drug Intermediates CDMO Services Market
This report focuses on global and United States Generic Drug Intermediates CDMO Services market, also covers the segmentation data of other regions in regional level and county level.
The global Generic Drug Intermediates CDMO Services revenue was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
The market prospects for Generic Drug Intermediates CDMO (Contract Development Manufacturing Organization) Services are expected to be strong. The demand for generic drugs continues to rise due to their cost-effectiveness and increasing focus on accessible healthcare. Generic drug manufacturers often seek specialized services from CDMOs for efficient and streamlined processes in the development and manufacturing of drug intermediates. CDMOs offer expertise, regulatory compliance, and cost-effective manufacturing solutions. As the pharmaceutical industry strives to meet the growing demand for generic drugs, the market for Generic Drug Intermediates CDMO Services is projected to expand, providing pharmaceutical companies with essential support to deliver high-quality and affordable medications.
Global Generic Drug Intermediates CDMO Services Scope and Market Size
Generic Drug Intermediates CDMO Services market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Generic Drug Intermediates CDMO Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the Generic Drug Intermediates CDMO Services market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.



By Company


Euroapi
Cambrex
Recipharm
Thermo Fisher Scientific
Wuxi New Drug Development
Pharmaron Beijing
Asymchem Laboratories
Porton Pharma Solutions
ChengDa Pharmaceuticals
Segment by Type
Process Optimization of Generic Intermediates
Production of Generic Intermediates

Segment by Application


Pharmaceutical Enterprise
Laboratory
Other
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Generic Drug Intermediates CDMO Services definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Generic Drug Intermediates CDMO Services companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Generic Drug Intermediates CDMO Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Generic Drug Intermediates CDMO Services revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Generic Drug Intermediates CDMO Services Product Introduction
1.2 Global Generic Drug Intermediates CDMO Services Outlook 2018 VS 2022 VS 2033
1.2.1 Global Generic Drug Intermediates CDMO Services Market Size for the Year 2018-2033
1.2.2 United States Generic Drug Intermediates CDMO Services Market Size for the Year 2018-2033
1.3 Generic Drug Intermediates CDMO Services Market Size, United States VS Global, 2018 VS 2022 VS 2033
1.3.1 The Market Share of United States Generic Drug Intermediates CDMO Services in Global, 2018 VS 2022 VS 2033
1.3.2 The Growth Rate of Generic Drug Intermediates CDMO Services Market Size, United States VS Global, 2018 VS 2022 VS 2033
1.4 Generic Drug Intermediates CDMO Services Market Dynamics
1.4.1 Generic Drug Intermediates CDMO Services Industry Trends
1.4.2 Generic Drug Intermediates CDMO Services Market Drivers
1.4.3 Generic Drug Intermediates CDMO Services Market Challenges
1.4.4 Generic Drug Intermediates CDMO Services Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Generic Drug Intermediates CDMO Services by Type
2.1 Generic Drug Intermediates CDMO Services Market Segment by Type
2.1.1 Process Optimization of Generic Intermediates
2.1.2 Production of Generic Intermediates
2.2 Global Generic Drug Intermediates CDMO Services Market Size by Type (2018, 2022 & 2033)
2.3 Global Generic Drug Intermediates CDMO Services Market Size by Type (2018-2033)
2.4 United States Generic Drug Intermediates CDMO Services Market Size by Type (2018, 2022 & 2033)
2.5 United States Generic Drug Intermediates CDMO Services Market Size by Type (2018-2033)
3 Generic Drug Intermediates CDMO Services by Application
3.1 Generic Drug Intermediates CDMO Services Market Segment by Application
3.1.1 Pharmaceutical Enterprise
3.1.2 Laboratory
3.1.3 Other
3.2 Global Generic Drug Intermediates CDMO Services Market Size by Application (2018, 2022 & 2033)
3.3 Global Generic Drug Intermediates CDMO Services Market Size by Application (2018-2033)
3.4 United States Generic Drug Intermediates CDMO Services Market Size by Application (2018, 2022 & 2033)
3.5 United States Generic Drug Intermediates CDMO Services Market Size by Application (2018-2033)
4 Global Generic Drug Intermediates CDMO Services Competitor Landscape by Company
4.1 Global Generic Drug Intermediates CDMO Services Market Size by Company
4.1.1 Global Key Companies of Generic Drug Intermediates CDMO Services, Ranked by Revenue (2022)
4.1.2 Global Generic Drug Intermediates CDMO Services Revenue by Player (2018-2023)
4.2 Global Generic Drug Intermediates CDMO Services Concentration Ratio (CR)
4.2.1 Generic Drug Intermediates CDMO Services Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Generic Drug Intermediates CDMO Services in 2022
4.2.3 Global Generic Drug Intermediates CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Generic Drug Intermediates CDMO Services Head office and Area Served
4.4 Global Key Players of Generic Drug Intermediates CDMO Services, Product and Application
4.5 Global Key Players of Generic Drug Intermediates CDMO Services, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Generic Drug Intermediates CDMO Services Market Size by Company
4.7.1 Key Players of Generic Drug Intermediates CDMO Services in United States, Ranked by Revenue (2022)
4.7.2 United States Generic Drug Intermediates CDMO Services Revenue by Players (2021, 2022 & 2023)
5 Global Generic Drug Intermediates CDMO Services Market Size by Region
5.1 Global Generic Drug Intermediates CDMO Services Market Size by Region: 2018 VS 2022 VS 2033
5.2 Global Generic Drug Intermediates CDMO Services Market Size by Region (2018-2033)
5.2.1 Global Generic Drug Intermediates CDMO Services Market Size by Region: 2018-2023
5.2.2 Global Generic Drug Intermediates CDMO Services Market Size by Region (2024-2033)
6 Americas
6.1 Americas Generic Drug Intermediates CDMO Services Market Size YoY Growth 2018-2033
6.2 Americas Generic Drug Intermediates CDMO Services Market Size by Type
6.2.1 Americas Generic Drug Intermediates CDMO Services Market Size by Type (2018-2023)
6.2.2 Americas Generic Drug Intermediates CDMO Services Market Size by Type (2024-2033)
6.2.3 Americas Generic Drug Intermediates CDMO Services Market Share by Type (2018-2033)
6.3 Americas Generic Drug Intermediates CDMO Services Market Size by Application
6.3.1 Americas Generic Drug Intermediates CDMO Services Market Size by Application (2018-2023)
6.3.2 Americas Generic Drug Intermediates CDMO Services Market Size by Application (2024-2033)
6.3.3 Americas Generic Drug Intermediates CDMO Services Market Share by Application (2018-2033)
6.4 Americas Generic Drug Intermediates CDMO Services Market Facts & Figures by Country (2018, 2022 & 2033)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Generic Drug Intermediates CDMO Services Market Size YoY Growth 2018-2033
7.2 EMEA Generic Drug Intermediates CDMO Services Market Size by Type
7.2.1 EMEA Generic Drug Intermediates CDMO Services Market Size by Type (2018-2023)
7.2.2 EMEA Generic Drug Intermediates CDMO Services Market Size by Type (2024-2033)
7.2.3 EMEA Generic Drug Intermediates CDMO Services Market Share by Type (2018-2033)
7.3 EMEA Generic Drug Intermediates CDMO Services Market Size by Application
7.3.1 EMEA Generic Drug Intermediates CDMO Services Market Size by Application (2018-2023)
7.3.2 EMEA Generic Drug Intermediates CDMO Services Market Size by Application (2024-2033)
7.3.3 EMEA Generic Drug Intermediates CDMO Services Market Share by Application (2018-2033)
7.4 EMEA Generic Drug Intermediates CDMO Services Market Facts & Figures by Country (2018, 2022 & 2033)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Generic Drug Intermediates CDMO Services Market Size YoY Growth 2018-2033
8.2 China Generic Drug Intermediates CDMO Services Market Size by Type
8.2.1 China Generic Drug Intermediates CDMO Services Market Size by Type (2018-2023)
8.2.2 China Generic Drug Intermediates CDMO Services Market Size by Type (2024-2033)
8.2.3 China Generic Drug Intermediates CDMO Services Market Share by Type (2018-2033)
8.3 China Generic Drug Intermediates CDMO Services Market Size by Application
8.3.1 China Generic Drug Intermediates CDMO Services Market Size by Application (2018-2023)
8.3.2 China Generic Drug Intermediates CDMO Services Market Size by Application (2024-2033)
8.3.3 China Generic Drug Intermediates CDMO Services Market Share by Application (2018-2033)
9 APAC (excluding China)
9.1 APAC Generic Drug Intermediates CDMO Services Market Size YoY Growth 2018-2033
9.2 APAC Generic Drug Intermediates CDMO Services Market Size by Type
9.2.1 APAC Generic Drug Intermediates CDMO Services Market Size by Type (2018-2023)
9.2.2 APAC Generic Drug Intermediates CDMO Services Market Size by Type (2024-2033)
9.2.3 APAC Generic Drug Intermediates CDMO Services Market Share by Type (2018-2033)
9.3 APAC Generic Drug Intermediates CDMO Services Market Size by Application
9.3.1 APAC Generic Drug Intermediates CDMO Services Market Size by Application (2018-2023)
9.3.2 APAC Generic Drug Intermediates CDMO Services Market Size by Application (2024-2033)
9.3.3 APAC Generic Drug Intermediates CDMO Services Market Share by Application (2018-2033)
9.4 APAC Generic Drug Intermediates CDMO Services Market Facts & Figures by Country (2018, 2022 & 2033)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Euroapi
10.1.1 Euroapi Company Details
10.1.2 Euroapi Business Overview
10.1.3 Euroapi Generic Drug Intermediates CDMO Services Introduction
10.1.4 Euroapi Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023)
10.1.5 Euroapi Recent Development
10.2 Cambrex
10.2.1 Cambrex Company Details
10.2.2 Cambrex Business Overview
10.2.3 Cambrex Generic Drug Intermediates CDMO Services Introduction
10.2.4 Cambrex Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023)
10.2.5 Cambrex Recent Development
10.3 Recipharm
10.3.1 Recipharm Company Details
10.3.2 Recipharm Business Overview
10.3.3 Recipharm Generic Drug Intermediates CDMO Services Introduction
10.3.4 Recipharm Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023)
10.3.5 Recipharm Recent Development
10.4 Thermo Fisher Scientific
10.4.1 Thermo Fisher Scientific Company Details
10.4.2 Thermo Fisher Scientific Business Overview
10.4.3 Thermo Fisher Scientific Generic Drug Intermediates CDMO Services Introduction
10.4.4 Thermo Fisher Scientific Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023)
10.4.5 Thermo Fisher Scientific Recent Development
10.5 Wuxi New Drug Development
10.5.1 Wuxi New Drug Development Company Details
10.5.2 Wuxi New Drug Development Business Overview
10.5.3 Wuxi New Drug Development Generic Drug Intermediates CDMO Services Introduction
10.5.4 Wuxi New Drug Development Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023)
10.5.5 Wuxi New Drug Development Recent Development
10.6 Pharmaron Beijing
10.6.1 Pharmaron Beijing Company Details
10.6.2 Pharmaron Beijing Business Overview
10.6.3 Pharmaron Beijing Generic Drug Intermediates CDMO Services Introduction
10.6.4 Pharmaron Beijing Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023)
10.6.5 Pharmaron Beijing Recent Development
10.7 Asymchem Laboratories
10.7.1 Asymchem Laboratories Company Details
10.7.2 Asymchem Laboratories Business Overview
10.7.3 Asymchem Laboratories Generic Drug Intermediates CDMO Services Introduction
10.7.4 Asymchem Laboratories Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023)
10.7.5 Asymchem Laboratories Recent Development
10.8 Porton Pharma Solutions
10.8.1 Porton Pharma Solutions Company Details
10.8.2 Porton Pharma Solutions Business Overview
10.8.3 Porton Pharma Solutions Generic Drug Intermediates CDMO Services Introduction
10.8.4 Porton Pharma Solutions Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023)
10.8.5 Porton Pharma Solutions Recent Development
10.9 ChengDa Pharmaceuticals
10.9.1 ChengDa Pharmaceuticals Company Details
10.9.2 ChengDa Pharmaceuticals Business Overview
10.9.3 ChengDa Pharmaceuticals Generic Drug Intermediates CDMO Services Introduction
10.9.4 ChengDa Pharmaceuticals Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023)
10.9.5 ChengDa Pharmaceuticals Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Generic Drug Intermediates CDMO Services Market Size United States VS Global, CAGR (2018 VS 2022 VS 2033)
Table 2. Generic Drug Intermediates CDMO Services Market Trends
Table 3. Generic Drug Intermediates CDMO Services Market Drivers
Table 4. Generic Drug Intermediates CDMO Services Market Challenges
Table 5. Generic Drug Intermediates CDMO Services Market Restraints
Table 6. Global Generic Drug Intermediates CDMO Services Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 7. United States Generic Drug Intermediates CDMO Services Market Size by Type: 2018 VS 2022 VS 2033 (US$ Million)
Table 8. Global Generic Drug Intermediates CDMO Services Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 9. United States Generic Drug Intermediates CDMO Services Market Size by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 10. Global Key Companies of Generic Drug Intermediates CDMO Services, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global Generic Drug Intermediates CDMO Services Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Generic Drug Intermediates CDMO Services Revenue Share by Player, 2018-2023
Table 13. Global Generic Drug Intermediates CDMO Services Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Generic Drug Intermediates CDMO Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Drug Intermediates CDMO Services as of 2022)
Table 15. Global Key Players of Generic Drug Intermediates CDMO Services, Headquarters and Area Served
Table 16. Global Key Players of Generic Drug Intermediates CDMO Services, Product and Application
Table 17. Global Key Players of Generic Drug Intermediates CDMO Services, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Generic Drug Intermediates CDMO Services in United States, Ranked by Revenue (2022) & (US$ Million)
Table 20. United States Generic Drug Intermediates CDMO Services Revenue by Players, (US$ Million), 2021, 2022 & 2023
Table 21. United States Generic Drug Intermediates CDMO Services Revenue Share by Players, 2021, 2022 & 2023
Table 22. Global Generic Drug Intermediates CDMO Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 23. Global Generic Drug Intermediates CDMO Services Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Generic Drug Intermediates CDMO Services Market Size Forecast by Region (2024-2033) & (US$ Million)
Table 25. Americas Generic Drug Intermediates CDMO Services Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Generic Drug Intermediates CDMO Services Market Size by Type (2024-2033) & (US$ Million)
Table 27. Americas Generic Drug Intermediates CDMO Services Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Generic Drug Intermediates CDMO Services Market Size by Application (2024-2033) & (US$ Million)
Table 29. Americas Generic Drug Intermediates CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 30. Americas Generic Drug Intermediates CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Generic Drug Intermediates CDMO Services Market Size by Country (2024-2033) & (US$ Million)
Table 32. EMEA Generic Drug Intermediates CDMO Services Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Generic Drug Intermediates CDMO Services Market Size by Type (2024-2033) & (US$ Million)
Table 34. EMEA Generic Drug Intermediates CDMO Services Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Generic Drug Intermediates CDMO Services Market Size by Application (2024-2033) & (US$ Million)
Table 36. EMEA Generic Drug Intermediates CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. EMEA Generic Drug Intermediates CDMO Services Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Generic Drug Intermediates CDMO Services Market Size by Country (2024-2033) & (US$ Million)
Table 39. China Generic Drug Intermediates CDMO Services Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Generic Drug Intermediates CDMO Services Market Size by Type (2024-2033) & (US$ Million)
Table 41. China Generic Drug Intermediates CDMO Services Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Generic Drug Intermediates CDMO Services Market Size by Application (2024-2033) & (US$ Million)
Table 43. China Generic Drug Intermediates CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. APAC Generic Drug Intermediates CDMO Services Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Generic Drug Intermediates CDMO Services Market Size by Type (2024-2033) & (US$ Million)
Table 46. APAC Generic Drug Intermediates CDMO Services Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Generic Drug Intermediates CDMO Services Market Size by Application (2024-2033) & (US$ Million)
Table 48. APAC Generic Drug Intermediates CDMO Services Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. APAC Generic Drug Intermediates CDMO Services Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Generic Drug Intermediates CDMO Services Market Size by Region (2024-2033) & (US$ Million)
Table 51. Euroapi Company Details
Table 52. Euroapi Business Overview
Table 53. Euroapi Generic Drug Intermediates CDMO Services Product
Table 54. Euroapi Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023) & (US$ Million)
Table 55. Euroapi Recent Development
Table 56. Cambrex Company Details
Table 57. Cambrex Business Overview
Table 58. Cambrex Generic Drug Intermediates CDMO Services Product
Table 59. Cambrex Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023) & (US$ Million)
Table 60. Cambrex Recent Development
Table 61. Recipharm Company Details
Table 62. Recipharm Business Overview
Table 63. Recipharm Generic Drug Intermediates CDMO Services Product
Table 64. Recipharm Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023) & (US$ Million)
Table 65. Recipharm Recent Development
Table 66. Thermo Fisher Scientific Company Details
Table 67. Thermo Fisher Scientific Business Overview
Table 68. Thermo Fisher Scientific Generic Drug Intermediates CDMO Services Product
Table 69. Thermo Fisher Scientific Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023) & (US$ Million)
Table 70. Thermo Fisher Scientific Recent Development
Table 71. Wuxi New Drug Development Company Details
Table 72. Wuxi New Drug Development Business Overview
Table 73. Wuxi New Drug Development Generic Drug Intermediates CDMO Services Product
Table 74. Wuxi New Drug Development Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023) & (US$ Million)
Table 75. Wuxi New Drug Development Recent Development
Table 76. Pharmaron Beijing Company Details
Table 77. Pharmaron Beijing Business Overview
Table 78. Pharmaron Beijing Generic Drug Intermediates CDMO Services Product
Table 79. Pharmaron Beijing Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023) & (US$ Million)
Table 80. Pharmaron Beijing Recent Development
Table 81. Asymchem Laboratories Company Details
Table 82. Asymchem Laboratories Business Overview
Table 83. Asymchem Laboratories Generic Drug Intermediates CDMO Services Product
Table 84. Asymchem Laboratories Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023) & (US$ Million)
Table 85. Asymchem Laboratories Recent Development
Table 86. Porton Pharma Solutions Company Details
Table 87. Porton Pharma Solutions Business Overview
Table 88. Porton Pharma Solutions Generic Drug Intermediates CDMO Services Product
Table 89. Porton Pharma Solutions Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023) & (US$ Million)
Table 90. Porton Pharma Solutions Recent Development
Table 91. ChengDa Pharmaceuticals Company Details
Table 92. ChengDa Pharmaceuticals Business Overview
Table 93. ChengDa Pharmaceuticals Generic Drug Intermediates CDMO Services Product
Table 94. ChengDa Pharmaceuticals Revenue in Generic Drug Intermediates CDMO Services Business (2018-2023) & (US$ Million)
Table 95. ChengDa Pharmaceuticals Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Generic Drug Intermediates CDMO Services Product Picture
Figure 2. Global Generic Drug Intermediates CDMO Services Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Generic Drug Intermediates CDMO Services Market Size 2018-2033 (US$ Million)
Figure 4. United States Generic Drug Intermediates CDMO Services Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 5. United States Generic Drug Intermediates CDMO Services Market Size 2018-2033 (US$ Million)
Figure 6. United States Generic Drug Intermediates CDMO Services Market Share in Global 2018-2033
Figure 7. Generic Drug Intermediates CDMO Services Report Years Considered
Figure 8. Product Picture of Process Optimization of Generic Intermediates
Figure 9. Product Picture of Production of Generic Intermediates
Figure 10. Global Generic Drug Intermediates CDMO Services Market Share by Type in 2022 & 2033
Figure 11. Global Generic Drug Intermediates CDMO Services Market Size by Type (2018-2033) & (US$ Million)
Figure 12. Global Generic Drug Intermediates CDMO Services Market Share by Type (2018-2033)
Figure 13. United States Generic Drug Intermediates CDMO Services Market Share by Type in 2022 & 2033
Figure 14. United States Generic Drug Intermediates CDMO Services Market Size by Type (2018-2033) & (US$ Million)
Figure 15. United States Generic Drug Intermediates CDMO Services Market Share by Type (2018-2033)
Figure 16. Product Picture of Pharmaceutical Enterprise
Figure 17. Product Picture of Laboratory
Figure 18. Product Picture of Other
Figure 19. Global Generic Drug Intermediates CDMO Services Market Share by Application in 2022 & 2033
Figure 20. Global Generic Drug Intermediates CDMO Services Market Size by Application (2018-2033) & (US$ Million)
Figure 21. Global Generic Drug Intermediates CDMO Services Market Share by Application (2018-2033)
Figure 22. United States Generic Drug Intermediates CDMO Services Market Share by Application in 2022 & 2033
Figure 23. United States Generic Drug Intermediates CDMO Services Market Size by Application (2018-2033) & (US$ Million)
Figure 24. United States Generic Drug Intermediates CDMO Services Market Share by Application (2018-2033)
Figure 25. The Top 5 and 10 Largest Companies of Generic Drug Intermediates CDMO Services in the World: Market Share by Generic Drug Intermediates CDMO Services Revenue in 2022
Figure 26. Global Generic Drug Intermediates CDMO Services Market Size Market Share by Region: 2018 VS 2022 VS 2033
Figure 27. Global Generic Drug Intermediates CDMO Services Market Share by Region (2018-2033)
Figure 28. Americas Generic Drug Intermediates CDMO Services Market Size Growth Rate 2018-2033 (US$ Million)
Figure 29. Americas Generic Drug Intermediates CDMO Services Market Share by Type (2018-2033)
Figure 30. Americas Generic Drug Intermediates CDMO Services Market Share by Application (2018-2033)
Figure 31. United States Generic Drug Intermediates CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 32. Canada Generic Drug Intermediates CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 33. Mexico Generic Drug Intermediates CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 34. Brazil Generic Drug Intermediates CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 35. EMEA Generic Drug Intermediates CDMO Services Market Size Growth Rate 2018-2033 (US$ Million)
Figure 36. EMEA Generic Drug Intermediates CDMO Services Market Share by Type (2018-2033)
Figure 37. EMEA Generic Drug Intermediates CDMO Services Market Share by Application (2018-2033)
Figure 38. Europe Generic Drug Intermediates CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 39. Middle East Generic Drug Intermediates CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 40. Africa Generic Drug Intermediates CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 41. China Generic Drug Intermediates CDMO Services Market Size Growth Rate 2018-2033 (US$ Million)
Figure 42. China Generic Drug Intermediates CDMO Services Market Share by Type (2018-2033)
Figure 43. China Generic Drug Intermediates CDMO Services Market Share by Application (2018-2033)
Figure 44. APAC Generic Drug Intermediates CDMO Services Market Size Growth Rate 2018-2033 (US$ Million)
Figure 45. APAC Generic Drug Intermediates CDMO Services Market Share by Type (2018-2033)
Figure 46. APAC Generic Drug Intermediates CDMO Services Market Share by Application (2018-2033)
Figure 47. Japan Generic Drug Intermediates CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 48. South Korea Generic Drug Intermediates CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 49. China Taiwan Generic Drug Intermediates CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 50. Southeast Asia Generic Drug Intermediates CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 51. India Generic Drug Intermediates CDMO Services Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 52. Euroapi Revenue Growth Rate in Generic Drug Intermediates CDMO Services Business (2018-2023)
Figure 53. Cambrex Revenue Growth Rate in Generic Drug Intermediates CDMO Services Business (2018-2023)
Figure 54. Recipharm Revenue Growth Rate in Generic Drug Intermediates CDMO Services Business (2018-2023)
Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Generic Drug Intermediates CDMO Services Business (2018-2023)
Figure 56. Wuxi New Drug Development Revenue Growth Rate in Generic Drug Intermediates CDMO Services Business (2018-2023)
Figure 57. Pharmaron Beijing Revenue Growth Rate in Generic Drug Intermediates CDMO Services Business (2018-2023)
Figure 58. Asymchem Laboratories Revenue Growth Rate in Generic Drug Intermediates CDMO Services Business (2018-2023)
Figure 59. Porton Pharma Solutions Revenue Growth Rate in Generic Drug Intermediates CDMO Services Business (2018-2023)
Figure 60. ChengDa Pharmaceuticals Revenue Growth Rate in Generic Drug Intermediates CDMO Services Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries